NanoRepro AG (XTER:NN6) Forward Dividend Yield %: 0.00% (As of Jul. 02, 2026)


XTER:NN6 NanoRepro AG XTER:NN6
51 GF Score
Price €1.97
GF Value €1.00
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is NanoRepro AG Forward Dividend Yield %?

NanoRepro AG XTER:NN6 -0.76% 51 Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates XTER:NN6 with a GF Score™ of 51/100 and a GF Value™ of €1.00 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 61 Medical Diagnostics & Research companies, NanoRepro AG ranks worse than 1639342.62% on this metric.

As of today (2026-07-02), the Forward Annual Dividend Yield of NanoRepro AG is 0.00%.

As of today (2026-07-02), the Trailing Annual Dividend Yield of NanoRepro AG is 0.00%.

XTER:NN6's Forward Dividend Yield % is not ranked *
in the Medical Diagnostics & Research industry.
Industry Median: 1.86
* Ranked among companies with meaningful Forward Dividend Yield % only.

NanoRepro AG's Dividends per Share for the six months ended in Jun. 2025 was €0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

NanoRepro AG  (XTER:NN6) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

NanoRepro AG Forward Dividend Yield % Related Terms

XTER:NN6 vs TMO, DHR, IDXX: Forward Dividend Yield % Comparison

For the Diagnostics & Research subindustry, NanoRepro AG's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NanoRepro AG Forward Dividend Yield % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, NanoRepro AG's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where NanoRepro AG's Forward Dividend Yield % falls into.


XTER:NN6
51GF Score
NanoRepro AG XTER:NN6
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

NanoRepro AG Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
NanoRepro AG (XTER:NN6) has a Forward Dividend Yield % of 0.00% as of Jul. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NanoRepro AG and its competitors. According to the industry distribution chart, NanoRepro AG ranks #999999 out of 61 companies in the Medical Diagnostics & Research industry.
Is NanoRepro AG's Forward Dividend Yield % too high?
NanoRepro AG's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, NanoRepro AG ranks #999999 out of 61 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, NanoRepro AG has a GF Score™ of 51/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does NanoRepro AG's Forward Dividend Yield % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, NanoRepro AG ranks #999999 out of 61 companies for Forward Dividend Yield %. This places NanoRepro AG in the lower half of its industry. The industry median Forward Dividend Yield % is 1.86. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Diagnostics & Research company?
The median Forward Dividend Yield % among Medical Diagnostics & Research companies is 1.86, based on 61 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on NanoRepro AG and its competitors. For the Medical Diagnostics & Research industry, the median Forward Dividend Yield % is 1.86 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NanoRepro AG's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NanoRepro AG stock overvalued right now?
Based on GuruFocus' analysis, NanoRepro AG (XTER:NN6) is currently considered Significantly Overvalued. The stock's GF Value™ is €1.00, compared to a current price of €1.97 — trading 96.5% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. NanoRepro AG's overall GF Score™ is 51/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For NanoRepro AG (XTER:NN6), the current Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is NanoRepro AG (XTER:NN6) Overvalued in 2026?

Based on GuruFocus' analysis, NanoRepro AG stock appears to be overvalued. The current stock price of €1.97 is trading 96.5% above its estimated GF Value™ of €1.00. GuruFocus considers NanoRepro AG to be Significantly Overvalued.

Key valuation signals for XTER:NN6:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: €1.00 vs. price of €1.97 (96.5% above fair value)
  • GF Score™: 51/100 with 6 warning signs

No single metric tells the full story. See the XTER:NN6 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

NanoRepro AG Business Description

Address Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
51GF Score

Get the complete analysis for XTER:NN6

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.97
Price
€1.00
GF Value